Webinar Recording: The Critical Importance Of Early Risk Detection With A Special Feature Addressing COVID-19
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the Webinar The clinical research industry is in the midst of adopting Risk-Based Quality Management (RBQM) as a primary method for managing quality. RBQM encourages less reliance on traditional on-site monitoring including 100% source data verification/review (SDV/SDR), and greater reliance on centralized […]
CluePoints’ Central Statistical Monitoring Supports Business Continuity As Coronavirus Impacts Clinical Trial Operations
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the adoption of modern clinical trial technologies King of Prussia, PA: CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing […]
CluePoints’ Risk-Based Quality Management (RBQM) Software Wins At Scrip Awards 2019
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards. CluePoints’ Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software was recognized for the essential role it plays in […]
As Demand For RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractors. This coincides with another distinction which saw CluePoints scoop Scale up of the Year […]
FDA Extends CRADA With CluePoints To Further Explore A Data-Driven Approach To Quality Oversight In Clinical Trials
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research. Misconduct in clinical research, including, but not limited to the falsification or omission of data in reporting research results, places all subjects in that trial […]
ICH E6 (R2) Compliance Webinar Series Available To Watch Now!
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT HOW AM I GOING TO IMPLEMENT THIS AND REALIZE THE VALUE?” This is the question on everyone’s mind and one that we’ve addressed many times with Sponsors & CROs. This comprehensive two-part on-demand webinar series answers all the questions […]
Parexel Strengthens Risk-Based Monitoring Offering With CluePoints’ New Advanced Statistical Capabilities
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs. WAYNE, PA, June 18, 2019– Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today announced its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution […]
CluePoints Experiences Continued Rapid Growth As Demand For RBx Rises
WAYNE, PA – April 09, 2019: CluePoints, a leading provider of Risk-Based Study Execution(RBx) and Data Quality Oversight solutions for clinical trials, has announced a progressive outlook of continued and significant global growth and continued investment in people and technology throughout North America, Europe and Asia Pacific. In response to client need and demand for RBx- a […]
New! Registration Open For CluePoints’ RBM Roadshows – Pick From San Francisco Or La Jolla!
We’re delighted to announce that registration for CluePoints’ US Risk-Based Quality Management Roadshow is now open. Taking place in January 2019, these roadshows will provide you the opportunity to network with Industry Subject-Matter Experts and learn more about RBx: A complete risk-based approach to clinical trials. If like many other sponsors and CROs, especially those with smaller, early-phase studies, your […]
Announcing The CluePoints Data Quality Challenge
Are you struggling with how to assess the true value of improving data quality and integrity through Risk-Based Monitoring (RBM)? Now is your chance to find out first-hand how ICH E6 R2 has given the industry, not only the chance to become much more resource efficient while increasing data quality, but to realise huge cost […]